← Leaderboards
Lucy Spalluto
Vanderbilt University Medical Center
$687,550
Attributed
$687,550
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $240.6K · FY2021–23$250K$187.5K$125K$62.5K$0
'21
'22
'23
Funding mix
By agency
NIH$687,550 · 2
By mechanism
U54$687,550 · 2
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- John C Gore$64,324,679
- Maria Blanca Piazuelo$1,687,389
- Sarah V Suiter$1,409,591
- Kimberly Brown Dahlman$634,993
- Alicia Beeghly-Fadiel$111,242
Others in their field
Other Emerging Leaders on “Early Screening”
- Bryan Faller · Decatur Memorial Hospital$29,346,991
- John Damon Chodera · Sloan-Kettering Inst Can Research$26,381,758
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
- Leonard Freedman · Leidos Biomedical Research, Inc.$10,640,817
- Anna Upton · Global Alliance For Tb Drug Development$10,496,979
- Amit Singal · Ut Southwestern Medical Center$10,297,917
Research focus
Early ScreeningEthnic DiversityData CollectionDiagnosisAgedEducationBrca1 MutationAge GroupConsolidated Framework For Implementation ResearchAdministratorBreast Cancer Early DetectionBreast Cancer Risk Assessment ToolBreast Cancer Risk FactorCancer CareCancer CenterCancer DiagnosisCancer Health DisparityBrca2 MutationAdoptionClinicClinical CareClinical PracticeCommunitiesEvidence Base
Grant awards (3)
Project 1: BRAVE Strategy (Breast cancer Risk Assessment, achieVing Equity)$227,315
U54 · FY2023 · CA · contact PI
Project 1: BRAVE Strategy (Breast cancer Risk Assessment, achieVing Equity)$219,632
U54 · FY2022 · CA · contact PI
Project 1: BRAVE Strategy (Breast cancer Risk Assessment, achieVing Equity)$240,603
U54 · FY2021 · CA · contact PI